Permeation characteristics of 8-methoxypsoralen through human skin; Relevance to clinical treatment

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 4, 1996, Pages 357-366

  Anigbogu, A N C ^a   Williams, A C ^a   Barry, B W ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; OCTANOL; PHOTOSENSITIZING AGENT; WATER;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG CLEARANCE; DRUG PENETRATION; DRUG SOLUBILITY; DRUG UPTAKE; EPIDERMIS; HUMAN; HUMAN TISSUE; PARTITION COEFFICIENT; PSORIASIS; PUVA; SKIN PENETRATION; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

EID: 0029889653     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05933.x     Document Type: Article

References (33)

1. Akhter, S. A., Bennett, S. L., Waller, I. L., Barry. B. W. (1984) An automated diffusion apparatus for studying skin penetration. Int. J. Pharm. 21: 17-26
2. Barry, B. W. (1983) Dermatological Formulations; Percutaneous Absorption. Marcel Dekker, Inc., New York and Basel
3. British Pharmaceutical Codex (1979) 11th edition, Pharmaceutical Press, pp 646-648
4. Calzavara-Pinton, P. G., Ortel, B., Honigsmann, H., Zane, C., De Panfils, G. (1994) Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology 189: 256-259
5. Cleek, R. L., Bunge, A. L. (1993) A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm. Res. 10: 497-506
6. Coldman, M. F., Poulsen, B. J., Higuchi, T. (1969) Enhancement of percutaneous absorption by the use of volatile : non-volatile systems as vehicles. J. Pharm. Sci. 58: 1098-1102
7. El-Mofty, A. M. (1948) A preliminary clinical report on the treatment of leucoderma with Ammi majus Linn. J. Royal Egyptian Med. Assoc. 31: 651-655
8. Fisher, T., Hartvig, P., Bondestam, U. (1980) Plasma concentrations of bath treatment and oral administration of trioxsalen. Acta Dermatol. Venereol. (Stockholm.) 60: 177-179
9. Gazith, K., Schalla, M. D., Bauer, E., Schaefer, H. (1978) 8-Methoxypsoralen (8-MOP) in human skin: penetration kinetics. J. Invest. Dermatol. 71: 126-130
10. Harrison, S. M., Barry, B. W., Dugard, P. H. (1984) Effects of freezing on human skin permeability. J. Pharm. Pharmacol. 36: 261-262
11. Haycock, G. B., Schwartz, G. J., Wisotsky, D. H. (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J. Pediatr. 93: 62
12. Kammerau, B., Klebe, U., Zesch, A., Schaefer, H. (1976) Penetration, permeation and resorption of 8-methoxypsoralen. Comparative in vitro and in vivo studies after topical application. Arch. Dermatol. Res. 255: 31-42
13. Kenney, J. A. (1974) Vitiligo treated by psoralens. Arch. Dermatol. 103: 475-480
14. Kligman, A. M., Christophers, E. (1963) Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88: 70-73
15. Lamaud, E., Schalla, W. (1984) Influence of UV-irradiation on penetration of hydrocortisone: in vivo study in hairless rat skin. Br. J. Dermatol. 111 (suppl. 27): 152-157
16. Lowe, V. S., Weingarten, D., Bourgett, T., Moy, L. S. (1986) PUVA therapy from psoriasis: comparison of oral and bath-water delivery of 8-MOP. J. Am. Acad. Dermatol. 14: 754-760
17. Marks, R. (1981) Measurement of biological ageing in human epidermis. Br. J. Dermatol. 104: 627-633
18. Morison, W. L. (1991) Psoralens and UVA radiation. In: Morison, W. L. (ed.) Phototherapy of Skin Diseases. Raven Press, New York, pp 43-52
19. Neild, V. S., Scott, L. V. (1982) Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen. Br. J. Dermatol. 106: 199-203
20. Petrozzi, J. W., Kaidley, K. M., Kligman, A. M. (1977) Topical methoxsalen and blacklight in treatment of psoriasis. Acta Dermatol. 113: 292-296
21. Pham, C. T., Koo, J. Y. M. (1993) Plasma levels of 8-methoxypsoralen after topical paint PUVA. J. Am. Acad. Dermatol. 28: 460-466
22. Schaefer, H., Schalla, W. (1986) Human cutaneous pharmaco-kinetics in vivo. In: Marks, R., Plewig, G. (eds) Skin Models, Springer-Verlag, pp 94-102
23. Schalla, W., Schaefer, H., Kammerau, B., Zesch, A. (1976) Pharmaco-kinetics of 8-methoxypsoralen (8-MOP) after oral and local application. J. Invest. Dermatol. 88: 258-259
24. Steiner, I., Prey, T., Gschnait, F., Washüttl, J., Greither, F. (1978) Serum levels of 8-methoxypsoralen 2 hours after oral administration. Acta Dermatol. Venereol. (Stockh.) 58: 185-186
25. Thomas, S. E., O'Sullivan, J., Balac, N. (1991) Plasma levels of 8-methoxypsoralen following oral or bath-water treatment. Br. J. Dermatol. 125: 56-58
26. Turowski, G., Kapinska-Mrowka, M., Pietrzyk, J. J. (1980) HLA antigens in psoriasis. Arch. Immunol. Ther. Exp. 28: 119-126
27. Valvani, S. C., Yalkowsky, S. H. (1980) Solubility and partitioning in drug design. In: Yalkowsky, S. H., Sinkula, A. A., Valvani, S. C. (eds) Physical Chemical Properties of Drugs. Medicinal Research Series, Volume 10, Marcel Dekker Inc., New York and Basel, pp 201-229
28. Wagner, G., Hofmann, C., Busch, U., Schmid, J., Plewig, G. (1979) 8-MOP plasma levels in PUVA problem cases with psoriasis. Br. J. Dermatol. 101: 285-292
29. Walter, J. F., Voorhees, J. J. (1973) Psoriasis improved by the psoralen plus black light. Acta Derm. Venereol. (Stockholm) 53: 469-472
30. Weber, G. (1974) Combined 8-methoxypsoralen and blacklight therapy of psoriasis: technique and results. Br. J. Dermatol. 90: 317-323
31. Wester, R. C., Bucks, D. A., Maibach, H. I. (1983) In vivo percutaneous absorption of hydrocortisone in psoriatic and normal volunteers. J. Am. Acad. Dermatol. 8: 645-647
32. Williams, A. C., Barry, B. W. (1991) The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluor-ouracil) drugs. Int. J. Pharm. 74: 157-168
33. Zackheim, H. S., Feldmann, R. J., Lindsay, C., Maibach, H. I. (1977) Percutaneous absorption of 1,3-bis(2-chloroethyl)-1-nitrosurea (BCNU, carmustine) in mycosis fungoides. Br. J. Dermatol. 97: 65-67